The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved ...

Having MS results in columnist Desiree Lama waging a sometimes silent battle against pain, but she's learning to listen to ...

Higher blood levels of a marker of nerve damage are associated with lower daily activity in people with progressive forms of ...

A digital lifestyle program was linked to lasting improvements in several measures reported by multiple sclerosis patients, a study says.

Specifically, CSF levels of CCL2, a proinflammatory molecule that’s increased in MS, and SCF, a molecule thought to be ...

A study found 55 DNA methylation regions differed in pediatric MS, with Epstein-Barr virus infection emerging as the top-ranked pathway.

Columnist Desiree Lama offers advice about how parents of adult children with MS can assist them in their journey with their ...

Breathing problems are common in advanced MS, and patients should be screened for them as part of routine care, a study suggested.

A new study confirms that EBV infection increases thew risk of MS and shows that common herpesviruses have differing roles in the disease.

MRI study finds signs of myelin and iron loss in RRMS, but not in AQP4-positive NMOSD, using a specialized imaging technique.

European Union regulators recommended that the infusion therapy Ocrevus be approved to treat relapsing MS in patients ages 10 and older.